FRLAX
Price
$20.03
Change
-$0.15 (-0.74%)
Updated
Sep 20 closing price
VGSNX
Price
$21.46
Change
-$0.07 (-0.33%)
Updated
Sep 20 closing price
Ad is loading...

FRLAX vs VGSNX

Header iconFRLAX vs VGSNX Comparison
Open Charts FRLAX vs VGSNXBanner chart's image
Franklin Real Estate Securities Adv
Price$20.03
Change-$0.15 (-0.74%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.46
Change-$0.07 (-0.33%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FRLAX vs VGSNX Comparison Chart
Loading...
VS
FRLAX vs. VGSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRLAX is a StrongBuy and VGSNX is a Buy.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 70.5B vs. FRLAX (296M). VGSNX pays higher dividends than FRLAX: VGSNX (4.01) vs FRLAX (2.19). FRLAX was incepted earlier than VGSNX: FRLAX (28 years) vs VGSNX (21 years). FRLAX is a more actively managed with annual turnover of: 10.69 vs. VGSNX (9.00). FRLAX has a lower initial minimum investment than VGSNX: FRLAX (100000) vs VGSNX (5000000). VGSNX annual gain was more profitable for investors over the last year : 26.90 vs. FRLAX (19.83). VGSNX return over 5 years is better than : 26.84 vs. FRLAX (-7.83).
FRLAXVGSNXFRLAX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years21 years-
Gain YTD11.78013.45288%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets296M70.5B0%
Annual Yield % from dividends2.194.0155%
Returns for 1 year19.8326.9074%
Returns for 3 years-7.093.64-195%
Returns for 5 years-7.8326.84-29%
Returns for 10 years23.4087.2927%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPRX3.620.16
+4.62%
Kiora Pharmaceuticals Inc.
TRU101.141.17
+1.17%
TransUnion
SVRA4.440.01
+0.23%
Savara
KYMR46.44-0.86
-1.82%
Kymera Therapeutics
GALT2.71-0.06
-2.17%
Galectin Therapeutics